Neonataldiagnostik-Unternehmen InfanDx AG etabliert wissenschaftlichen Beirat
January 19, 2022 04:00 ET
|
AKAMPION
Team erfahrener wissenschaftlicher Experten zur Beratung von InfanDx bei diagnostischem Bedarf und Produktkonzepten in der neonatalen Akut- und IntensivmedizinSchwerpunkte der Eröffnungssitzung:...
Neonatal Diagnostics Company InfanDx AG Establishes Scientific Advisory Board
January 19, 2022 04:00 ET
|
AKAMPION
Team of seasoned scientific advisors to further guide InfanDx on diagnostic needs and product concepts in neonatal acute and critical careInaugurating meeting focused on positioning of HypoxE® Test in...
Eisbach Bio and MD Anderson announce strategic collaboration to develop medicines targeting epigenetic machinery in oncology
January 18, 2022 09:00 ET
|
AKAMPION
MUNICH and HOUSTON; January 18, 2022 ― Eisbach Bio GmbH and The University of Texas MD Anderson Cancer Center today announced a strategic research collaboration to jointly discover and develop...
BellaSeno Announces Publication of First-in-Human Data of its Lead Program Senella
December 07, 2021 04:00 ET
|
AKAMPION
- Successful initial treatment of pectus excavatum patient in Australia - Data published in the European Journal of Plastic Surgery confirms Bellaseno’s novel approach in soft tissue engineering ...
ImmunOs Therapeutics Appoints Steve Coats, PhD, as Chief Development Officer
December 06, 2021 04:00 ET
|
AKAMPION
- Company adds significant immunotherapy development expertise to its management team- Clinical trial of lead compound IOS-1002 to start in 2022 Schlieren (Zurich Area), Switzerland. – December...
ImmunOs Therapeutics´ Lead Program Shows Strong Anti-Tumor Activity In Vivo and In Vitro
November 15, 2021 03:00 ET
|
AKAMPION
- Promising data presented at Society for Immunotherapy of Cancer 36th Annual Meeting (SITC) - Multi-functional agent targeting three innate immune checkpoint receptors - Potential as monotherapy and...
Curexsys Appoints Christian Eckert as Chief Operating Officer
October 20, 2021 04:00 ET
|
AKAMPION
- Strengthened management team headed by Jörg Neermann as CEO Goettingen, Germany, October 20, 2021 - Curexsys GmbH, a leader in the emerging field of therapeutic exosomes, today announced the...
ImmunOs Therapeutics Announces Poster Presentation at the Society for Immunotherapy of Cancer 36th Annual Meeting (SITC)
October 13, 2021 04:15 ET
|
AKAMPION
- Preclinical data highlighting mode-of-action of lead program iosH2 Schlieren (Zurich Area), Switzerland. – October 13, 2021 – ImmunOs Therapeutics AG, a Swiss biotechnology company developing...
ImmunOs Therapeutics Appoints Jeffrey Abbey as Chief Operating Officer, Establishes Clinical Advisory Board
September 01, 2021 04:00 ET
|
AKAMPION
- Company prepares for further growth and entry into clinical development- Prof. Andrew Scott, Dmitriy Zamarin, MD, PhD, Prof. Dr. med. Dirk Jäger, and Jeffrey M. Bockman, PhD, appointed as clinical...
Neonatal-Diagnostik-Unternehmen InfanDx AG ernennt Dr. Gunter Weiss zum Chief Operating Officer
August 04, 2021 04:00 ET
|
AKAMPION
Dr. Weiss verfügt über mehr als 15 Jahre Erfahrung mit der Entwicklung von Biomarkern und In-vitro-Diagnostika Unternehmen hat gezielte Rekrutierungskampagne für die nächste Phase der...